Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case-control study.
Chinthaka Bhagya SamaranayakeGregory KeirSimon A A SladerT TsengKhoa TranJames AndersonAndrew McCannColm McCabeJohn W UphamPublished in: ERJ open research (2021)
Assessment of efficacy and safety of DOACs in treatment of pulmonary embolisms in obese patients provides reassurance that treatment with DOACs carries similar rates of recurrent VTE and bleeding complications to warfarin https://bit.ly/2VdrSXX.
Keyphrases
- direct oral anticoagulants
- venous thromboembolism
- atrial fibrillation
- obese patients
- bariatric surgery
- pulmonary hypertension
- metabolic syndrome
- type diabetes
- clinical trial
- weight loss
- liver failure
- gastric bypass
- risk factors
- adipose tissue
- intensive care unit
- cross sectional
- body mass index
- combination therapy
- aortic dissection